Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Clascoterone Cream 1% in Healthy Chinese Adults
NCT06454708Phase 1Completed
- Sponsor
- Zhejiang Sunshine Mandi Pharmaceutical Co., Ltd.
- Start
- Aug 2024
- Primary completion
- Aug 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of clascoterone in acne vulgaris, sponsored by Zhejiang Sunshine Mandi Pharmaceutical Co., Ltd. Primary endpoints: Time to maximum plasma concentration at Day 1, Maximum plasma concentration at Day 1 and 4 more. Started Aug 2024; status: completed.
02
Drugs
clascoterone
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT06454708.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06454708.